Equistar Veterinary Services Limited 09208172 false 2023-12-01 2024-11-30 2024-11-30 The principal activity of the company is provision of veterinary activities. Digita Accounts Production Advanced 6.30.9574.0 true false 09208172 2023-12-01 2024-11-30 09208172 2024-11-30 09208172 core:RetainedEarningsAccumulatedLosses 2024-11-30 09208172 core:ShareCapital 2024-11-30 09208172 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 09208172 bus:SmallEntities 2023-12-01 2024-11-30 09208172 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 09208172 bus:FullAccounts 2023-12-01 2024-11-30 09208172 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 09208172 bus:RegisteredOffice 2023-12-01 2024-11-30 09208172 bus:Director1 2023-12-01 2024-11-30 09208172 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 09208172 core:FurnitureFittings 2023-12-01 2024-11-30 09208172 core:PlantMachinery 2023-12-01 2024-11-30 09208172 countries:England 2023-12-01 2024-11-30 09208172 2023-11-30 09208172 2022-12-01 2023-11-30 09208172 2023-11-30 09208172 core:RetainedEarningsAccumulatedLosses 2023-11-30 09208172 core:ShareCapital 2023-11-30 09208172 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 iso4217:GBP xbrli:pure

Registration number: 09208172

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 November 2024

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

(Registration number: 09208172)
Abridged Balance Sheet as at 30 November 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

54,753

47,204

Current assets

 

Stocks

21,847

24,868

Debtors

42,169

26,031

Cash at bank and in hand

 

20,104

53,754

 

84,120

104,653

Creditors: Amounts falling due within one year

(15,271)

(11,497)

Net current assets

 

68,849

93,156

Total assets less current liabilities

 

123,602

140,360

Provisions for liabilities

21,448

17,314

Net assets

 

145,050

157,674

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

144,950

157,574

Total equity

 

145,050

157,674

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 18 August 2025
 

Mr C Pinkham

Director

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 November 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Home Farm Offices
Home Farm Road
Wilton
Salisbury
SP2 8PJ

These financial statements were authorised for issue by the director on 18 August 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern
The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 November 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance

Fixtures and fittings

15% reducing balance

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 4 (2023 - 4).

4

Tangible assets

Total
£

Cost or valuation

At 1 December 2023

101,171

Additions

20,841

At 30 November 2024

122,012

Depreciation

At 1 December 2023

53,969

Charge for the year

13,290

At 30 November 2024

67,259

Carrying amount

At 30 November 2024

54,753

At 30 November 2023

47,204